Eileen M O’Reilly
@EileenMOReilly
Followers
6K
Following
7K
Media
11
Statuses
4K
Oncologist MSK. TCD alum. Interests Pancreas, Hepatobiliary, GI Cancers, IRB Chair, Editor, Data & safety, Drug Development, Clinical trials, Alliance GI, NCTN
Manhattan, NY
Joined May 2019
Exciting to see these results out! Lots to build on - congratulations @ superb MSK pancreas team (no biases!) and complex insightful analyses led by @CentralParkWMD @MSKCancerCenter and as #ASCO23 winds down…. back to the real work of implementing all the learnings to practice!.
Pembro + olaparib maintenece #POLAR trial (B&C) in non-BRCA potential #HRD stage IV #PancreaticCancer n=30. Well-tolerated. 30% had no progression for > 6mo WITHOUT chemo. Deep science & POLAR A #BRCA awaited. #gratitude & 💜to MSK team & patients #ASCO23
4
21
93
RT @Aiims1742: Received a Texas sized farewell from my @MDAndersonNews family, complete with an exceptional brisket from top chef @eugeneko….
0
4
0
RT @GABOUALFA: Always an honor and delight for @MSKCancerCenter @MSK_DeptOfMed @EileenMOReilly @GABOUALFA to join with our dear @AUB_Lebano….
0
1
0
RT @YJanjigianMD: That feeling when 7+ years of work lands on the front page of @NEJM—and one of the people I respect most, @KoheiShitara ,….
0
24
0
0
55
0
RT @oncodaily: Join Dr. Tanios Bekaii-Saab (@GIcancerDoc) and Dr. Eileen O’Reilly (@EileenMOReilly) for the 2025 International Symposium on….
0
2
0
RT @OncLive: We present the #FiveUnder5 🕘, your go-to roundup of the top 5️⃣ #oncology videos of the week. View the clips 📹: https://t.co/….
0
6
0
RT @MacarullaTeresa: We start the second day of #ESMOGI25 with controversy session: molecular testing for all PDAC. Talia Golan review the….
0
7
0
RT @CathyEngMD: Looking forward to: #Keynotespeaker today at 1PM, @Aiims1742 will be speaking on "Molecular biology insights in #pancreati….
0
2
0
RT @CathyEngMD: Here we go! @myESMO #ESMOGI25 @MacarullaTeresa and Drs. Cervantes, Ducreux and Van Cutsem! #ESMOAmbassadors #cancer #Canc….
0
1
0
RT @CathyEngMD: Day 2 and bumped into the lovely @Betzabe100 before our AM sessions: Multi-D #Rectalcancer (Madrid room) and NGS on #pancr….
0
3
0
RT @CathyEngMD: 🙏🏻 to all that showed up for our multi-D #rectalcancer session at @myESMO. GREAT 👏 discussion with Drs. Prager, Garcia-Agu….
0
3
0
RT @CathyEngMD: Dr. Julian Taieb is giving an excellent overview of #ctDNA and prognosis and its challenges in the Valencia room now. @my….
0
5
0
RT @CathyEngMD: 👏Fantastic lecture on creation of the definition of oligometastatic disease for #esophageal #cancer Dr. Hannake van Laarho….
0
2
0
RT @Juanmaoconnor: For now, it’s all about raising awareness and building a proper care program for these patients. Down the line, we need….
0
2
0
RT @LorenzaRimassa: I had the honor to discuss the TALENTACE phase 3 trial of on-demand TACE+atezo-bev in patients with intermediate stage….
0
5
0
RT @MyriamChalabi: Keynote lecture now by @FASinicropeMD on CRC screening using blood-based tests and more. Chaired by Eric van Cutsem. @my….
0
12
0
RT @CathyEngMD: Day 3 @myESMO but need to acknowledge my fantastic colleagues at @bmsnews @GIcancerDoc @DrShubhamPant @MallaMidhun @PMBolan….
0
4
0
RT @EvelynWongYT: @BenWestphalen delivered compelling insights into diving deep into the #BRAF pathway in colorectal cancer. #ESMOGI25 By s….
0
4
0
RT @EvelynWongYT: Dr Hanneke van Laarhoven stresses the need for a clear definition of oligometastatic disease in esophagogastric cancer to….
0
4
0
RT @EvelynWongYT: 🤘🏻Powerful insights from @CathyEngMD at #ESMOGI25 on the rising tide of early-onset GI cancer. Highlighting the real-worl….
0
8
0